As an undergraduate, I used FTICR Mass Spectrometry to identify and characterize expressed proteins from bacterial and recombinant systems, with Fred McLafferty at Cornell University, where I received BAs in both chemistry and biology with concentrations in biochemistry and molecular and cell biology. After, I completed my PhD research with Evan Williams and Rich Mathies in the Department of Chemistry at the University of California, Berkeley. There I used microfluidic separations, surface sampling probes, and multidimensional mass spectrometry, focusing on the application of integrations of these tools to allow "better" sampling.

I continued to focus on fundamentals and applications of liquid extraction probes and mass spectrometry, first as a postdoctoral researcher at Oak Ridge National Laboratory in the Organic and Biological Mass Spectrometry Group with Gary Van Berkel, and subsequently as a Senior Scientist at Prosolia, working through analytical sampling, chemical imaging, and applied biophysics. This company was acquired by Waters in 2019.

Leaning more toward the microfluidic separation side of things, I joined the team at Intabio--based in Fremont, CA--to help building devices to facilitate protein-drug development via imaging charge variant separations in advance of ionization and MS analysis. This company was acquired by Sciex in 2021 to bring to the world integrated chip-based icIEF-UV/MS analysis for biothereaputics. I hope to continue use my background to develop techniques to help people understand things, ranging from new workflows and data visualization tools to analyze important and complex biophysical processes, AND new processes to improve how they engage in the work of solving complex problems.

I enjoy asking unexpected questions, scrutinizing representations of science (and non-science) on television and in other media, and making art and other curious things on the side.